Clearpoint Neuro Liabilities 2024

Clearpoint Neuro Aktienanalyse

What does Clearpoint Neuro do?

Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and marketing of advanced medical products and systems. The company was founded in 1998 and is headquartered in Irvine, California. Clearpoint Neuro's primary goal is to provide better care and treatment for patients with neurological disorders. Clearpoint Neuro was originally founded in 1998 under the name MRI Intervention to meet the market demand for innovative navigation systems for minimally invasive brain procedures. The company's initial products included imaging devices used during surgery. Since then, the company has expanded its product portfolio and strengthened its market position by focusing on core tasks in the field of medical technology. In 2011, MRI Intervention rebranded as Clearpoint Neuro to accommodate its growing product portfolio. The company now primarily focuses on the development and marketing of platform technologies for the control of minimally invasive instruments during neurosurgical procedures. Its customers include hospitals and research institutions that specialize in neurological and neuroscience applications. Clearpoint Neuro has built an extremely successful business model that specializes in providing advanced medical technology to benefit patients. The company works closely with leading neurosurgeons and researchers to understand the needs of patients and develop the most advanced technologies aimed at improving patient treatment. Clearpoint Neuro is a B2B (Business to Business) company that sells its products and services to hospitals and research institutions to ensure that its products are used by medical professionals with appropriate education and experience. The company also has a strong presence in the academic world, where it focuses on collaborating with laboratories and universities to advance the latest developments in technology and research. The divisions of Clearpoint Neuro include medical product areas developed from its technology base, which are described in more detail in the following sections. ClearPoint System ClearPoint is an intraoperative MRI system that is available as a core component of neurosurgical intervention platforms. It uses advanced technology for real-time localization and navigation of instruments to perform minimally invasive brain surgeries. It utilizes imaging technologies to enable navigation and coordination during the surgical procedure. ClearPoint Neuro Therapies ClearPoint Neuro Therapies includes three main areas: "DBS," "MRI-Guided Focused Ultrasound," and "Laser Therapy." DBS (Deep Brain Stimulation) is a minimally invasive neural therapy that involves the insertion of thin electrodes into the brain using a specially existing surgical technique to treat degenerative diseases, particularly Parkinson's disease. Another highly innovative therapy option is MRI-Guided Focused Ultrasound therapy, which targets and precisely destroys cancer cells using focused ultrasound waves. ClearPoint Neuro is one of the leading providers of this advanced therapy. Laser therapy involves the destruction of selected neural cells using heat. ClearPoint Neuro Navigation ClearPoint Neuro's navigation technologies are leading in neurosurgery and research. Navigation allows for precise placement of needles in the brain to obtain biopsies under ultrasound guidance or to administer medication targetedly without damaging the brain. The system is used by neurosurgeons and researchers worldwide. In conclusion, Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and manufacturing of advanced systems and products for neurosurgery and research. The company has built a strong business model by working closely with leading neurosurgeons and researchers and developing the most advanced technologies aimed at improving the quality of patient care. The ClearPoint System, ClearPoint Neuro Therapies, and ClearPoint Neuro Navigation divisions play a significant role in its success. Clearpoint Neuro ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Clearpoint Neuro's Liabilities

Clearpoint Neuro's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Clearpoint Neuro's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Clearpoint Neuro's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Clearpoint Neuro's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Clearpoint Neuro’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Clearpoint Neuro stock

What is the level of liabilities of Clearpoint Neuro this year?

Clearpoint Neuro has a debt balance of 21.49 M USD this year.

What were the liabilities of Clearpoint Neuro compared to the previous year?

The liabilities of Clearpoint Neuro have increased by 15.53% increased compared to the previous year.

What are the consequences of high debt for investors of Clearpoint Neuro?

High liabilities can pose a risk for investors of Clearpoint Neuro, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Clearpoint Neuro?

Low liabilities mean that Clearpoint Neuro has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Clearpoint Neuro affect the company?

An increase in liabilities of Clearpoint Neuro can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Clearpoint Neuro affect the company?

A decrease in the liabilities of Clearpoint Neuro can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Clearpoint Neuro?

Some factors that can influence the liabilities of Clearpoint Neuro include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Clearpoint Neuro so important for investors?

The liabilities of Clearpoint Neuro are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Clearpoint Neuro take to modify the liabilities?

To change its liabilities, Clearpoint Neuro can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Clearpoint Neuro pay?

Over the past 12 months, Clearpoint Neuro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Clearpoint Neuro is expected to pay a dividend of 0 USD.

What is the dividend yield of Clearpoint Neuro?

The current dividend yield of Clearpoint Neuro is .

When does Clearpoint Neuro pay dividends?

Clearpoint Neuro pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Clearpoint Neuro?

Clearpoint Neuro paid dividends every year for the past 0 years.

What is the dividend of Clearpoint Neuro?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Clearpoint Neuro located?

Clearpoint Neuro is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clearpoint Neuro kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clearpoint Neuro from 8/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/1/2024.

When did Clearpoint Neuro pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Clearpoint Neuro in the year 2023?

In the year 2023, Clearpoint Neuro distributed 0 USD as dividends.

In which currency does Clearpoint Neuro pay out the dividend?

The dividends of Clearpoint Neuro are distributed in USD.